亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Novel Antibody for Inhibiting Nodal-Dependent Activity

技術優勢
High affinity to NodalHighly selectiveEasy to scale production
詳細技術說明
Novel monoclonal antibody that inhibits the binding of Nodal to the Activin receptor complex #therapeutics #antibody #biomedical #researchtool
*Abstract

Northwestern researchers, together with Italian collaborators, have characterized a monoclonal antibody that inhibits the activity of Nodal, a growth factor driving abnormal growth in a variety of cancers. In normal development, Nodal is important in maintaining stem cell pluripotency, and subsequently disappears in most normal adult tissues. The inventors discovered, however, that Nodal is reactivated in aggressive tumor cells and is also associated with invasive disease states across many cancer types. Currently, existing technologies for inhibiting Nodal signaling are based on suppressing Nodal expression using antisense technology or commercial polyclonal antibodies, and there is no available Nodal-based ELISA. The novel monoclonal antibody described here is highly selective and possesses a high affinity to Nodal, and can be used effectively as a capture antibody in a sandwich-based ELISA. In addition, because it is easy to scale the production of this antibody, it is an ideal candidate for pharmaceutical development. 

*Inventors
Mary Hendrix*Elisabeth Seftor Richard SeftorMenotti Ruvo AnnaMaria SandomenicoAntonio LeonardiLuca SanguignoLuigi StrizziZhila Khalkhali-Ellis
*Publications
Topczewska JM, Postovit L-M, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J and Hendrix MJC (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Medicine, 12, 925-932. Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M, Seftor EA, Stephens CR, Lai J, APC BioResource, Postovit L-M, Clements JA, Hendrix MJC (2011). Reactivation of Embryonic Nodal Signaling is Associated with Tumor Progression and Promotes the Growth of Prostate Cancer Cells. Prostate, 71(11).
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備